September 10, 2024 7:50am
Will volatility constrain sectors comings sessions post Monday’s ascension?
Pre-open Indications: 1 positive and 1 negative Indications.
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!
Never leave an investor uninformed
Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!
Tuesday: The pre-open Dow futures are DOWN -0.03% or (-14 points), the S&P futures are UP +0.03% or (+1 points) and the Nasdaq futures are DOWN -0.08% or (-14 points)
- Stock futures were down and fluctuating flat Tuesday after indexes rebounded from their worst week in 2024,
- European markets mixed as uncertainty weighs on sentiment,
- Asia-Pacific markets were mixed.
Henry’omics: We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies …
Monday: The Dow closed up +484.18 points or +1.20%, the S&P closed UP +62.63 points or +1.16% while the Nasdaq closed UP +193.77 points or +1.16%
- Monday’s advance/decline line ended with a positive close at the close of 24 incliner, 8 decliners and 3 flats
Economic Data Docket: NFIB Small Business Optimism, August (93.7 expected, 93.7 previously)
Ionis Pharmaceuticals (IONS) prices a $500.3 M public offering … https://www.regmedinvestors.com/articles/13608
Monday’s RegMed Investors (RMi) Closing bell: “rebound after multiple hard falls. Regaining ground, lost after the August jobs report slip reported. Focus is now on a fresh consumer inflation print due Wednesday; followed by the read-out on pricing from the producer inflation report on Thursday, the last inflation inputs before the Fed's policy decision on Sept. 18 … https://www.regmedinvestors.com/articles/13607
Q3/24:
- September – 1 positive and 4 negative close
- August – I neutral, 10 positive and 11 negative closes
- July: 1 market holiday. 1 day off, 6 negative, 1 neutral and 12 positive closes
Companies in my headlights – It’s your decision; I provide ideas and context:
I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths. A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.
Positive Indications:
Monday, Friday, Thursday, Wednesday and last Tuesday closing “numbers” with aftermarket/pre-market dollar ($) and cent ($0.00) value and percentage (%)
Vericel (VCEL -$1.33 after Friday’s -$1.88 after Thursday’s -$0.87, Wednesday’s -$1.07 and Tuesday’s -$2.61 with a positive +$0.42 or +0.96% aftermarket
Negative Indications:
Monday, Friday, Thursday, Wednesday and last Tuesday closing “numbers” with aftermarket/pre-market dollar ($) and cent ($0.00) value and percentage (%)
Ionis Pharmaceuticals (IONS) closed up +$1.44 after Friday’s -$1.26 after Thursday’s +$0.50 and Wednesday’s +$0.34 with a negative -$3.33 or -6.89% aftermarket… with notice of an offering
The BOTTOM LINE: US stock futures slipped into the red on Tuesday, as investors geared up for a looming consumer inflation report seen as crucial to determining the size of the first US interest-rate cut in years. <Yahoo Finance>
Moving forward, I believe the cell and gene therapy sector equities could be a bit rocky.
- With every dramatic upside for the oversold … it will last a few sessions until trading subtracts the ascension.
Traders and investors are nervous about the coming week’s economic releases …
- Bracing for a busy week of inflation-related data releases. On Wednesday, the highly anticipated Consumer Price Index (CPI) report is due, followed by Initial Jobless Claims and Producer Price Index (PPI) data on Thursday.
Stocks are set to begin reversing Monday's sharp rebound, which saw the major gauges surge over 1% as investors went post-rout bargain hunting.
- Volatility is stalking the markets as investors waver between hopes for a hefty 0.5% rate cut from the Federal Reserve and worries about risks of recession.
Welcome to my world of defining the “grey’ in our universe!
- Right up front, “I also hate to be so negative or contrarian but, this is a NO spin zone and facts are its product; I can always be WRONG but … I am mostly EARLY!”
- The sector is what it is, until it isn’t and even then, it doesn’t seem to be… as NOT much changes as the sector’s share pricing rides the waves of volatility, algorithms, electronic trading and short covering.
- I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives. Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.
